Subscribe now to recieve regular news and event updates from IMB.

5 minutes with Professor Kirill Alexandrov

5 minutes with Professor Kirill Alexandrov

"I would like to make the diagnostics of many diseases, including prostate cancer, as simple as it is today for diabetes."

What is your research focus?

By applying engineering principles to biology, my research group work to develop new technologies to detect abnormalities in the body simply and efficiently.

Is prostate cancer difficult to detect?

Prostate cancer is the most easily diagnosed and the most over treated cancer. The main problem with Prostate Cancer is distinguishing between slow growing and non-invasive tumors, which are the majority, and the small number of aggressive rapidly growing tumors.

What do you hope to achieve through your research?

We aim to give doctors and patients cheap and easy diagnostic tests that help them to detect, classify and monitor prostate cancer.   

I would like to make the diagnostics of many diseases, including prostate cancer, as simple as it is today for diabetes. We are currently developing a diagnostic device patients can simply insert into a mobile phone and read their diagnosis.  

How will this improve outcomes for those with prostate cancer?

We expect that it will increase the accuracy of the diagnosis and also simplify the long term monitoring of the condition. This is very important, as watchful waiting is one of the main approaches to the detection of Prostate Cancer.

Monitoring cancer bio-markers post surgery is essential for long-term survival, yet only about 50% of men adhere to annual tests. The ability to provide the patient with a self diagnosis tool and monitor self performed tests over the internet is expected to significantly improve long term survival.

What inspires you to use technology to help combat disease like prostate cancer?

I am motivated to give patients more control over and access to their information.


If you would like to help progress this technology to provide men with a simple tool to rapidly detect and monitor prostate cancer, please donate today

IMB Impact - Industry | May 2016

IMB Impact - Industry | May 2016

Innovation - Translation - Impact

Click here to read the full newsletter

Innovation - Translation - Impact

IMB is sharpening focus on translation and innovation

IMB has a strong track record in world class scientific research and discovery that is advancing new treatments and diagnostics for global health, and improving products and processes for industry and the environment.

Innovation is clearly seen by governments around the world as critical to economic progress and quality of life. In response, IMB is reinforcing its commitment to translational research. Research discoveries with the potential to benefit patients, industry and the community are encouraged and supported as early as possible in their development to ensure their application and use.

Innovation is embedded in everything we do at IMB, and our focus in 2016 is to ensure innovation is translated into impact. Our talented researchers now have unprecedented opportunities to achieve translational goals. We have established a translation sub-committee of the IMB Advisory Board, and declared 2016 the IMB Year of the Young Entrepreneur. Read more about these initiatives below, as well as news about just some of the IMB innovators who are making an impact.

Infographic: 35 patent families managed, 10 active ARC Linkage Projects with industry partners, 10 funded industry collaborations in 2015, 44 high-impact publications in 2015 (impact factor >10)

Innovating for agriculture IMB spin-out starts clinical trials for IBD drug Fighting cane toads with their own toxin


Woman holding sparkler Bob Christiansen Associate Professor Bev Robotham and Dr Anand Gautam
IMB's Year of the Young Entrepreneur
New sub-committee to support translation
New expertise on IMB Advisory Board

IMB Annual Report 2015 - Read it now


IMB Director Professor Brandon Wainwright elected as new chair of European Molecular Biology Laboratory (EMBL) Australia


On this site

Go to top